Stagwell Inc - Ordinary Sh...
|
Mark Penn J.
|
Director, Chief Executive Officer, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
151,648,741 |
151,778,741
|
-
|
|
-
|
Class A Common Stock |
Stagwell Inc - Ordinary Sh...
|
Mark Penn J.
|
Director, Chief Executive Officer, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
151,648,741 |
0
|
-
|
|
-
|
Class C Common Stock |
UWM Holdings Corporation -...
|
Mathew Ishbia
|
Director, President and CEO, Ten Percent Owner |
|
31 Mar 2025 |
13,028,909 |
13,028,909
|
-
|
|
-
|
Class A Common Stock |
UWM Holdings Corporation -...
|
Mathew Ishbia
|
Director, President and CEO, Ten Percent Owner |
|
31 Mar 2025 |
13,028,909 |
1,397,782,620
|
-
|
|
-
|
UWM Paired Interests |
UWM Holdings Corporation -...
|
Mathew Ishbia
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
31 Mar 2025 |
13,028,909 |
0
|
-
|
|
-
|
Class A Common Stock |
SS Innovations Internation...
|
Sudhir Srivastava
|
Director, Chairman and CEO, Ten Percent Owner |
|
31 Mar 2025 |
5,811,554 |
112,926,514
|
-
|
1.4 |
8,019,945
|
Common Stock, $0.0001 par value |
Mawson Infrastructure Grou...
|
Rahul Mewawalla
|
Director, Director, CEO, President, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
1,587,302 |
3,496,194
|
-
|
|
-
|
Common Stock |
Mawson Infrastructure Grou...
|
Rahul Mewawalla
|
Director, Director, CEO, President, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
1,587,302 |
0
|
-
|
|
-
|
Restricted Stock Units |
Intuitive Machines Inc - O...
|
Kamal Seyed Ghaffarian
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
31 Mar 2025 |
1,292,729 |
36,496,032
|
-
|
|
-
|
Common Units |
Intuitive Machines Inc - O...
|
Kamal Seyed Ghaffarian
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
31 Mar 2025 |
1,292,729 |
36,496,032
|
-
|
|
-
|
Class C Common Stock |
Crowdstrike Holdings Inc -...
|
George R. Kurtz
|
Director, PRESIDENT AND CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
1,246,087 |
0
(0%)
|
3%
|
|
0
|
Class A common stock |
Oncology Institute Inc (The)
|
Daniel Virnich
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
1,083,334 |
1,807,697
|
-
|
|
0
|
Common stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
1,072,607 |
1,072,607
|
-
|
|
-
|
Stock Option (right to buy) |
Crowdstrike Holdings Inc -...
|
George R. Kurtz
|
Director, PRESIDENT AND CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
1,021,038 |
0
(0%)
|
2%
|
|
0
|
Class A common stock |
Crowdstrike Holdings Inc -...
|
George R. Kurtz
|
Director, PRESIDENT AND CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
940,788 |
0
(0%)
|
2%
|
|
0
|
Class A common stock |
Pyxis Oncology Inc
|
Lara S. Sullivan
|
Director, President ,CEO & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
918,308 |
918,308
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arbutus Biopharma Corp
|
Tuan Nguyen
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
750,000 |
750,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arbutus Biopharma Corp
|
Tuan Nguyen
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
750,000 |
750,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
First Horizon Corporation
|
D. Bryan Jordan
|
Director, Chairman, President & CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
725,848 |
1,197,797
(0%)
|
0%
|
|
0
|
Common Stock |
Mawson Infrastructure Grou...
|
Rahul Mewawalla
|
Director, Director, CEO, President, Ten Percent Owner |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. |
31 Mar 2025 |
633,713 |
2,862,481
|
-
|
0.5 |
316,857
|
Common Stock |
ADT Inc
|
Donald M. Young
|
EVP & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
614,637 |
2,947,342
(0%)
|
0%
|
|
0
|
Common Stock |
Ryerson Holding Corp.
|
Edward J. Lehner
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
600,000 |
600,000
|
-
|
|
-
|
Restricted Stock Units |
Exelixis Inc
|
Michael M. Morrissey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
589,719 |
1,623,009
(0%)
|
0%
|
|
0
|
Common Stock |
ADT Inc
|
Jeff Likosar
|
Pres Corp Dev & Trans. & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
573,387 |
1,698,218
(0%)
|
0%
|
|
0
|
Common Stock |
ADT Inc
|
Jeff Likosar
|
Pres Corp Dev & Trans. & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
573,387 |
1,263,781
(0%)
|
0%
|
|
0
|
Common Stock |
ADT Inc
|
James D. DeVries
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
559,597 |
3,565,937
(0%)
|
0%
|
|
0
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
489,429 |
489,429
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
489,429 |
489,429
|
-
|
|
-
|
Restricted Stock Units |
Local Bounti Corp - Ordina...
|
Charles R. Schwab
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
31 Mar 2025 |
429,137 |
429,137
|
-
|
|
-
|
Series A Convertible Preferred Stock |
Pyxis Oncology Inc
|
Pamela Yanchik Connealy
|
CFO & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
414,163 |
414,163
|
-
|
|
-
|
Stock Option (Right to Buy) |
Stardust Power Inc.
|
Chris Celano
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
408,719 |
408,719
|
-
|
|
0
|
Common Stock |
ADT Inc
|
Jeff Likosar
|
Pres Corp Dev & Trans. & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
397,410 |
1,720,945
|
-
|
|
-
|
Employee Stock Option (right to buy) |
ADT Inc
|
Jeff Likosar
|
Pres Corp Dev & Trans. & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
397,410 |
1,720,945
|
-
|
|
-
|
Employee Stock Option (right to buy) |
ADT Inc
|
James D. DeVries
|
Director, Chairman, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
387,853 |
1,840,278
|
-
|
|
-
|
Employee Stock Option (right to buy) |
C3.ai Inc - Ordinary Share...
|
James Hageman Snabe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
360,000 |
370,000
|
-
|
|
0
|
Class A Common Stock |
ADT Inc
|
Donald M. Young
|
EVP & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
356,160 |
1,503,420
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Starwood Property Trust Inc
|
Barry S. Sternlicht
|
Director, CEO, Chairman of the Board |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
345,833 |
2,245,835
|
-
|
|
-
|
Restricted Stock Units |
Starwood Property Trust Inc
|
Barry S. Sternlicht
|
Director, CEO, Chairman of the Board |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
345,833 |
2,880,440
(1%)
|
0%
|
|
-
|
Common Stock |
Organon & Co.
|
Matthew M. Walsh
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
317,656 |
317,656
|
-
|
|
-
|
Stock Option (right to buy) |
Healthcare Triangle Inc
|
Lakshmanan Kannappan
|
Business Head |
Other type of transaction at price $ 0.00 per share. |
31 Mar 2025 |
304,180 |
324,180
|
-
|
|
0
|
Common Stock |
StoneX Group Inc
|
Sean M. O'Connor
|
Director, Executive Vice-Chairman-Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
300,000 |
1,057,167
(5%)
|
1%
|
|
0
|
Restricted Shares of Common Stock |
Hyperfine Inc - Ordinary S...
|
Thomas Teisseyre
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
300,000 |
382,213
|
-
|
|
0
|
Class A Common Stock |
Hyperfine Inc - Ordinary S...
|
Brett Hale
|
CFO and CAO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
300,000 |
300,000
|
-
|
|
0
|
Class A Common Stock |
CERo Therapeutics Holdings...
|
Brian G. Atwood
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
294,460 |
11,660
|
-
|
|
-
|
Pre-Funded Warrant |
CERo Therapeutics Holdings...
|
Brian G. Atwood
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
294,460 |
490,534
|
-
|
0.0 |
29
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Kazi Hasan
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
293,657 |
293,657
|
-
|
|
-
|
Restricted Stock Units |
Charles Schwab Corp.
|
Todd M. Ricketts
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
290,608 |
525,805
(0%)
|
0%
|
|
0
|
Common Stock |
Cidara Therapeutics Inc
|
Jeffrey Stein
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
275,000 |
275,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Ouster Inc - Ordinary Shar...
|
Angus Pacala
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
275,000 |
1,044,957
|
-
|
|
0
|
Common Stock |
Atlas Lithium Corporation
|
Marc Fogassa
|
Director, Chief Executive Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
265,153 |
4,983,231
|
-
|
|
0
|
Common Stock |
Pyxis Oncology Inc
|
Jitendra Wadhane
|
SVP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
263,782 |
263,782
|
-
|
|
-
|
Stock Option (Right to Buy) |
Organon & Co.
|
Joseph T. Morrissey
|
Head of Manufacturing |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
247,524 |
247,524
|
-
|
|
-
|
Stock Option (right to buy) |
AudioEye Inc
|
David Moradi
|
Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
241,444 |
1,105,867
(12%)
|
2%
|
|
0
|
Common Stock |
Abercrombie & Fitch Co. - ...
|
Fran Horowitz-Bonadies
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
230,096 |
811,703
(1%)
|
0%
|
|
0
|
Class A Common Stock |
Clear Channel Outdoor Hold...
|
Justin Cochrane
|
Former CEO, UK & Europe |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
221,759 |
1,191,623
(2%)
|
0%
|
|
0
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Kazi Hasan
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
220,243 |
220,243
|
-
|
|
-
|
Restricted Stock Units |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
218,267 |
218,267
|
-
|
|
-
|
Restricted Stock Units |
Dyne Therapeutics Inc
|
Erick J. Lucera
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
214,500 |
214,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Organon & Co.
|
Juan Camilo Arjona Ferreira
|
Head of R&D & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
198,019 |
198,019
|
-
|
|
-
|
Stock Option (right to buy) |
Oncology Institute Inc (The)
|
Robert Ross Carter
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
197,368 |
236,775
|
-
|
|
0
|
Class A Common Stock |
OPAL Fuels Inc - Ordinary ...
|
John Coghlin
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
195,772 |
195,772
|
-
|
|
-
|
Restricted Stock Units |
Hallador Energy Co
|
Brent K. Bilsland
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. |
31 Mar 2025 |
194,258 |
1,143,235
(3%)
|
0%
|
12.3 |
2,385,488
|
COMMON STOCK |
Stagwell Inc - Ordinary Sh...
|
Mark Penn J.
|
Director, Chief Executive Officer, Ten Percent Owner |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. |
31 Mar 2025 |
191,354 |
2,367,654
|
-
|
5.9 |
1,134,729
|
Class A Common Stock |
Organon & Co.
|
Rachel A. Stahler
|
Chief Information Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
181,518 |
181,518
|
-
|
|
-
|
Stock Option (right to buy) |
Organon & Co.
|
Kirke Weaver
|
Gen. Counsel & Corp. Secy. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
181,518 |
181,518
|
-
|
|
-
|
Stock Option (right to buy) |
Commercial Vehicle Group Inc
|
Chung Kin Cheung
|
EVP & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
181,132 |
316,352
(1%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Macy`s Inc
|
Adrian V. Mitchell
|
EVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
171,526 |
0
|
-
|
|
-
|
Restricted Stock Units |
Macy`s Inc
|
Adrian V. Mitchell
|
EVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
171,526 |
337,834
(0%)
|
0%
|
|
0
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
171,300 |
171,300
|
-
|
|
-
|
Restricted Stock Units |
Exelixis Inc
|
Christopher J. Senner
|
EVP and CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
170,009 |
1,009,264
(0%)
|
0%
|
|
0
|
Common Stock |
SS Innovations Internation...
|
Sudhir Srivastava
|
Director, Chairman and CEO, Ten Percent Owner |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2025 |
165,000 |
112,761,514
|
-
|
|
0
|
Common Stock, $0.0001 par value |
TJX Companies, Inc.
|
Ernie L. Herrman
|
Director, CEO & President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
164,450 |
630,639
(0%)
|
0%
|
|
0
|
Common Stock |
Oncology Institute Inc (The)
|
Jeremy N Castle
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
162,281 |
252,667
|
-
|
|
0
|
Common stock |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 100.22 per share. |
31 Mar 2025 |
162,008 |
47,001
(0%)
|
0%
|
100.2 |
16,236,571
|
Common Stock |
Exelixis Inc
|
Amy C. Peterson
|
EVP Prod Dev & Med Aff & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
159,383 |
506,472
(0%)
|
0%
|
|
0
|
Common Stock |
Exelixis Inc
|
Patrick J. Haley
|
EVP, Commercial |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
159,383 |
500,411
(0%)
|
0%
|
|
0
|
Common Stock |
Oncology Institute Inc (The)
|
Yale Podnos
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
157,088 |
236,137
|
-
|
|
0
|
Common stock |
Alto Ingredients Inc
|
Bryon T. McGregor
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
155,500 |
989,765
(1%)
|
0%
|
|
0
|
Common Stock |
Exelixis Inc
|
Jeffrey J. Hessekiel
|
EVP & General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
154,070 |
751,678
(0%)
|
0%
|
|
0
|
Common Stock |
Savara Inc
|
David A. Ramsay
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.78 per share. |
31 Mar 2025 |
150,000 |
2,513,642
(4%)
|
0%
|
2.8 |
416,250
|
Common Stock |
FitLife Brands Inc
|
Dayton Judd
|
Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.62 per share. |
31 Mar 2025 |
144,000 |
1,031,226
|
-
|
2.6 |
377,280
|
Common Stock |
FitLife Brands Inc
|
Dayton Judd
|
Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
144,000 |
0
|
-
|
|
-
|
Stock Options |
Ardent Health Partners Inc
|
Martin J. Bonick
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
134,927 |
1,126,984
|
-
|
|
0
|
Common Stock |
Exelixis Inc
|
Dana T. Aftab
|
CSO/EVP Disc & Trans Research |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
132,819 |
693,936
(0%)
|
0%
|
|
0
|
Common Stock |
FrontView REIT Inc.
|
Randall Starr
|
Director, Co-CEO and Co-President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
130,500 |
130,500
|
-
|
|
-
|
Restricted Stock Units |
Timken Co.
|
Richard Kyle
|
Director, Interim President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
126,700 |
286,963
(0%)
|
0%
|
|
0
|
Common Stock |
Organon & Co.
|
Vittorio Nisita
|
Head of Global Business Svcs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
123,762 |
123,762
|
-
|
|
-
|
Stock Option (right to buy) |
AT&T, Inc.
|
Pascal Desroches
|
Sr. Exec VP and CFO |
Grant, award, or other acquisition of securities at price $ 28.28 per share. |
31 Mar 2025 |
118,119 |
121,297
(0%)
|
0%
|
28.3 |
3,340,417
|
Common Stock |
Cipher Mining Inc
|
Tyler Page
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
113,225 |
5,530,662
|
-
|
|
-
|
Common Stock |
Cipher Mining Inc
|
Tyler Page
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
113,225 |
5,213,601
|
-
|
|
-
|
Restricted Stock Units |
Kohl`s Corp.
|
Nicholas David George Jones
|
Chief Merchandising Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
112,469 |
171,904
(0%)
|
0%
|
|
-
|
Common Stock |
Kohl`s Corp.
|
Jill Timm
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
112,469 |
360,309
(0%)
|
0%
|
|
-
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Darrell Birck
|
Executive Vice President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
110,122 |
110,122
|
-
|
|
-
|
Restricted Stock Units |
Stagwell Inc - Ordinary Sh...
|
Mark Penn J.
|
Director, Chief Executive Officer, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
31 Mar 2025 |
106,746 |
2,559,008
|
-
|
|
0
|
Class A Common Stock |
Clear Channel Outdoor Hold...
|
Justin Cochrane
|
Former CEO, UK & Europe |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share. |
31 Mar 2025 |
105,703 |
969,864
(1%)
|
0%
|
1.1 |
117,330
|
Common Stock |
Hallador Energy Co
|
Brent K. Bilsland
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
105,079 |
210,157
|
-
|
|
-
|
RSU |
Clear Channel Outdoor Hold...
|
Justin Cochrane
|
Former CEO, UK & Europe |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.11 per share. |
31 Mar 2025 |
104,782 |
1,086,841
(2%)
|
0%
|
1.1 |
116,308
|
Common Stock |
Abercrombie & Fitch Co. - ...
|
Fran Horowitz-Bonadies
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. |
31 Mar 2025 |
103,200 |
708,503
(1%)
|
0%
|
76.4 |
7,881,384
|
Class A Common Stock |
Macy`s Inc
|
Adrian V. Mitchell
|
EVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 12.88 per share. |
31 Mar 2025 |
101,633 |
236,201
(0%)
|
0%
|
12.9 |
1,309,033
|
Common Stock |
Silence Therapeutics Plc -...
|
Richard Ian Griffiths
|
Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
31 Mar 2025 |
100,000 |
9,861,299
|
-
|
|
-
|
American Depositary Shares |
Corcept Therapeutics Inc
|
Sean Maduck
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. |
31 Mar 2025 |
100,000 |
185,622
(0%)
|
0%
|
8.3 |
827,000
|
Common Stock |
Corcept Therapeutics Inc
|
Sean Maduck
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
100,000 |
300,000
|
-
|
|
-
|
Stock option (right to buy) |
Organon & Co.
|
Daniel Karp
|
Executive VP, Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
99,009 |
99,009
|
-
|
|
-
|
Stock Option (right to buy) |
Hallador Energy Co
|
Heath Aaron Lovell
|
President-Hallador Power |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. |
31 Mar 2025 |
98,835 |
166,867
(0%)
|
0%
|
12.3 |
1,213,694
|
COMMON STOCK |
First Guaranty Bancshares Inc
|
William K. Hood
|
Director |
Purchase of securities on an exchange or from another person at price $ 8.47 per share. |
31 Mar 2025 |
98,460 |
98,460
(1%)
|
1%
|
8.5 |
833,956
|
COMMON STOCK |
Palantir Technologies Inc ...
|
Ryan Taylor
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
98,177 |
32,307
|
-
|
|
-
|
Class B Common Stock |
Palantir Technologies Inc ...
|
Ryan Taylor
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
98,177 |
501,348
|
-
|
|
-
|
Class A Common Stock |
Kohl`s Corp.
|
Fred Hand
|
SEVP, Director of Stores |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
97,800 |
257,453
(0%)
|
0%
|
|
-
|
Common Stock |
Commercial Vehicle Group Inc
|
Aneezal H. Mohamed
|
Chief Legal Ofc, Cmp Ofc & Sec |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
96,855 |
271,475
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Procore Technologies Inc
|
Craig F. Courtemanche
|
Director, CEO & President, Chairman of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
93,437 |
815,616
|
-
|
|
0
|
Common Stock |
Hallador Energy Co
|
Brent K. Bilsland
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
89,179 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Commercial Vehicle Group Inc
|
Kristin S Mathers
|
Chief HR Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
86,038 |
161,269
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
OPAL Fuels Inc - Ordinary ...
|
Scott Edelbach
|
Executive Vice President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
85,650 |
85,650
|
-
|
|
-
|
Restricted Stock Units |
Frontdoor Inc.
|
William C. Cobb
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
84,144 |
84,144
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
80,704 |
138,026
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
80,704 |
80,703
|
-
|
|
-
|
Restricted Stock Units |
Purple Innovation Inc - Or...
|
Robert T. DeMartini
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
80,386 |
902,746
(4%)
|
0%
|
|
-
|
Class A Common Stock |
Purple Innovation Inc - Or...
|
Robert T. DeMartini
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
80,386 |
160,771
|
-
|
|
-
|
Restricted Stock Units |
TJX Companies, Inc.
|
Ernie L. Herrman
|
Director, CEO & President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. |
31 Mar 2025 |
79,512 |
551,127
(0%)
|
0%
|
121.8 |
9,684,562
|
Common Stock |
Corcept Therapeutics Inc
|
Sean Maduck
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 100.26 per share. |
31 Mar 2025 |
79,277 |
106,345
(0%)
|
0%
|
100.3 |
7,947,995
|
Common Stock |
Climb Bio Inc.
|
Douglas E. Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
78,873 |
78,873
|
-
|
|
-
|
Stock Option (Right to Buy) |
Techprecision Corp
|
Phillip E. Podgorski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
78,261 |
78,261
|
-
|
|
0
|
Common Stock |
National Vision Holdings Inc
|
Christopher Laden
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
78,248 |
78,248
|
-
|
|
-
|
Restricted Stock Units |
National Cinemedia Inc
|
Thomas F. Lesinski
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
77,500 |
0
|
-
|
|
-
|
Restricted Stock Units |
National Cinemedia Inc
|
Thomas F. Lesinski
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
77,500 |
407,041
(0%)
|
0%
|
|
0
|
Common Stock |
Beam Therapeutics Inc
|
John Evans
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
77,500 |
1,016,159
(2%)
|
0%
|
|
0
|
Common Stock |
Maiden Holdings Ltd
|
William T. Jarman
|
SVP & Chief Actuary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
76,086 |
238,341
(0%)
|
0%
|
|
0
|
Common Shares |
TJX Companies, Inc.
|
Carol Meyrowitz
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
75,437 |
245,084
(0%)
|
0%
|
|
0
|
Common Stock |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
75,000 |
0
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.52 per share. |
31 Mar 2025 |
75,000 |
119,009
(0%)
|
0%
|
16.5 |
1,239,000
|
Common Stock |
LifeMD Inc
|
Nicholas Alvarez
|
Chief Acquisition Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
75,000 |
580,000
|
-
|
|
0
|
Common Shares |
LifeMD Inc
|
Marc David Benathen
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
75,000 |
464,554
|
-
|
|
0
|
Common Stock |
Ryerson Holding Corp.
|
Edward J. Lehner
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
73,700 |
705,369
(1%)
|
0%
|
|
0
|
Common Stock (par value $0.01 per share) |
Core & Main Inc - Ordinary...
|
Mark R. Witkowski
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
73,458 |
73,458
|
-
|
|
-
|
Options (Rights to Buy) |
Kohl`s Corp.
|
Jennifer J. Kent
|
Sr.EVP & CLO & Corp. Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
73,350 |
203,825
(0%)
|
0%
|
|
-
|
Common Stock |
Kohl`s Corp.
|
Christie Raymond
|
Sr. EVP & Chief Marketing Off. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
73,350 |
256,701
(0%)
|
0%
|
|
-
|
Common Stock |
Local Bounti Corp - Ordina...
|
Charles R. Schwab
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.00 per share. |
31 Mar 2025 |
70,863 |
70,863
|
-
|
2 |
141,726
|
Common Stock |
Procore Technologies Inc
|
Steven Scott Davis
|
PRESIDENT PRODUCT & TECHNOLOGY |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
68,281 |
225,074
|
-
|
|
0
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
67,205 |
175,943
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
67,205 |
134,408
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
67,205 |
160,918
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
67,205 |
134,408
|
-
|
|
-
|
Restricted Stock Units |
British American Tobacco P...
|
Tadeu Marroco
|
Executive Director,Chief Executive Officer |
|
31 Mar 2025 |
67,109 |
214,067
(0%)
|
0%
|
|
0
|
Ords 0.25p |
Stagwell Inc - Ordinary Sh...
|
Frank P. Lanuto
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. |
31 Mar 2025 |
66,948 |
594,328
|
-
|
5.9 |
397,002
|
Class A Common Stock |
Dyne Therapeutics Inc
|
Erick J. Lucera
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,100 |
66,100
|
-
|
|
0
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Betsy L. Battle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
James J. Martell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Ashok Vemuri
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Kevin M. Fogarty
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Scott Dols
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Mark S. Comora
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Nadeem Nisar
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
66,073 |
66,073
|
-
|
|
-
|
Restricted Stock Units |
Maiden Holdings Ltd
|
Mark O. Heintzman
|
Senior Vice President Finance |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
65,217 |
104,432
(0%)
|
0%
|
|
0
|
Common Shares |
Procore Technologies Inc
|
Howard Fu
|
CFO & Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
64,687 |
209,400
|
-
|
|
0
|
Common Stock |
Organon & Co.
|
Matthew M. Walsh
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
64,640 |
64,640
|
-
|
|
-
|
Restricted Stock Units |
Lulus Fashion Lounge Holdi...
|
Crystal Landsem
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. |
31 Mar 2025 |
63,456 |
1,992,423
|
-
|
0.4 |
25,382
|
Common Stock |
Omega Healthcare Investors...
|
C. Taylor Pickett
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
62,623 |
572,046
|
-
|
|
-
|
Profits Interest Units |
Omega Healthcare Investors...
|
C. Taylor Pickett
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
62,623 |
888,588
|
-
|
|
-
|
OP Units |
Carvana Co. - Ordinary Sha...
|
Benjamin Huston
|
Chief Operating Officer |
|
31 Mar 2025 |
62,500 |
91,449
|
-
|
|
-
|
Class B Units |
RAPT Therapeutics Inc
|
Mary Ann Gray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
61,202 |
61,202
|
-
|
|
-
|
Director Stock Option (right to buy) |
Omega Healthcare Investors...
|
C. Taylor Pickett
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
60,460 |
825,965
|
-
|
|
-
|
OP Units |
Omega Healthcare Investors...
|
C. Taylor Pickett
|
Director, CHIEF EXECUTIVE OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
60,460 |
634,669
|
-
|
|
-
|
Profits Interest Units |
Starwood Property Trust Inc
|
Barry S. Sternlicht
|
Director, CEO, Chairman of the Board |
Other type of transaction at price $ 0.00 per share. |
31 Mar 2025 |
59,676 |
2,820,764
(0%)
|
0%
|
|
0
|
Common Stock |
Stagwell Inc - Ordinary Sh...
|
Jay Leveton
|
President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. |
31 Mar 2025 |
59,400 |
474,961
|
-
|
5.9 |
352,242
|
Class A Common Stock |
Alto Ingredients Inc
|
Bryon T. McGregor
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. |
31 Mar 2025 |
58,929 |
930,836
(1%)
|
0%
|
1.1 |
66,000
|
Common Stock |
Hallador Energy Co
|
Heath Aaron Lovell
|
President-Hallador Power |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
57,971 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Cipher Mining Inc
|
Tyler Page
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.30 per share. |
31 Mar 2025 |
57,802 |
5,472,860
|
-
|
2.3 |
132,945
|
Common Stock |
Lulus Fashion Lounge Holdi...
|
Mark Vos
|
President & CIO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. |
31 Mar 2025 |
57,563 |
1,294,776
|
-
|
0.4 |
23,025
|
Common Stock |
Procore Technologies Inc
|
Lawrence Joseph Stack
|
Chief Revenue Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
57,500 |
218,868
|
-
|
|
0
|
Common Stock |
ContextLogic Inc - Ordinar...
|
Jennifer Kwon Chou
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
56,701 |
56,701
|
-
|
|
-
|
Restricted Stock Unit |
Hallador Energy Co
|
Brent K. Bilsland
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. |
31 Mar 2025 |
55,849 |
1,087,388
(3%)
|
0%
|
12.3 |
685,826
|
Common Stock |
Alto Ingredients Inc
|
Robert R. Olander
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
55,500 |
280,556
(0%)
|
0%
|
|
0
|
Common Stock |
Alto Ingredients Inc
|
Todd E. Benton
|
COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
55,500 |
189,112
(0%)
|
0%
|
|
0
|
Common Stock |
AMMO Inc
|
Fred W. Wagenhals
|
Director, EXECUTIVE CHAIR |
|
31 Mar 2025 |
55,000 |
7,334,449
|
-
|
|
0
|
Common Stock |
Ardent Health Partners Inc
|
Alfred Lumsdaine
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
53,971 |
214,536
|
-
|
|
0
|
Common Stock |
Hallador Energy Co
|
Brent K. Bilsland
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. |
31 Mar 2025 |
53,032 |
1,090,203
(3%)
|
0%
|
12.3 |
651,233
|
COMMON STOCK |
Abercrombie & Fitch Co. - ...
|
Scott D. Lipesky
|
EVP and COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
52,296 |
163,734
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ryerson Holding Corp.
|
Edward J. Lehner
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.96 per share. |
31 Mar 2025 |
52,140 |
653,229
(1%)
|
0%
|
23.0 |
1,197,134
|
Common Stock (par value $0.01 per share) |
Lululemon Athletica inc.
|
Calvin R. McDonald
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
51,315 |
51,315
|
-
|
|
-
|
Stock Option (right to buy) |
Sarcos Technology and Robo...
|
Kristi Martindale
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 5.82 per share. |
31 Mar 2025 |
51,141 |
325,079
|
-
|
5.8 |
297,436
|
Common Stock |
Organon & Co.
|
Joseph T. Morrissey
|
Head of Manufacturing |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,369 |
50,369
|
-
|
|
-
|
Restricted Stock Units |
Anavex Life Sciences Corpo...
|
Athanasios Skarpelos
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Anavex Life Sciences Corpo...
|
Steffen Thomas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Anavex Life Sciences Corpo...
|
Peter Donhauser
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Anavex Life Sciences Corpo...
|
Claus van der Velden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Anavex Life Sciences Corpo...
|
Jiong Ma
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cidara Therapeutics Inc
|
Shane M. Ward
|
COO & CLO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.26 per share. |
31 Mar 2025 |
50,000 |
209,009
(0%)
|
0%
|
19.3 |
963,000
|
Common Stock |
Carvana Co. - Ordinary Sha...
|
Benjamin Huston
|
Chief Operating Officer |
|
31 Mar 2025 |
50,000 |
173,803
(0%)
|
0%
|
|
0
|
Class A Common Stock |
SharpLink Gaming Ltd
|
Leslie Bernhard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Restricted Stock Units |
SharpLink Gaming Ltd
|
Robert M. Gutkowski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Restricted Stock Units |
SharpLink Gaming Ltd
|
Obie McKenzie
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
50,000 |
50,000
|
-
|
|
-
|
Restricted Stock Units |
RAPT Therapeutics Inc
|
Wendye Robbins
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
49,432 |
49,432
|
-
|
|
-
|
Director Stock Option (right to buy) |
Unisys Corp.
|
Peter A. Altabef
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. |
31 Mar 2025 |
49,183 |
1,354,866
(2%)
|
0%
|
4.6 |
225,750
|
Common Stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
48,758 |
97,518
|
-
|
|
-
|
Restricted Stock Units |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
48,758 |
248,677
|
-
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Marshall A. Heinberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
48,346 |
48,346
|
-
|
|
-
|
Restricted Stock Unit |
Alto Ingredients Inc
|
James R Sneed
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
47,834 |
429,221
(0%)
|
0%
|
|
0
|
Common Stock |
Alto Ingredients Inc
|
Auste M. Graham
|
CLO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
47,834 |
277,958
(0%)
|
0%
|
|
0
|
Common Stock |
Sonim Technologies Inc
|
James S. Cassano
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
46,728 |
72,507
(0%)
|
0%
|
|
0
|
Common Stock |
Sonim Technologies Inc
|
Michael C. Mulica
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
46,728 |
101,110
(0%)
|
0%
|
|
0
|
Common Stock |
Sonim Technologies Inc
|
Jack Steenstra
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
46,728 |
72,520
(0%)
|
0%
|
|
0
|
Common Stock |
Biodesix Inc
|
John Patience
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
46,686 |
384,612
|
-
|
|
-
|
Common Stock |
Biodesix Inc
|
John Patience
|
Director, Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
46,686 |
0
|
-
|
|
-
|
Restricted Stock Units |
Biodesix Inc
|
Charles Watts
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
46,686 |
421,705
|
-
|
|
-
|
Common Stock |
Biodesix Inc
|
Charles Watts
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
46,686 |
0
|
-
|
|
-
|
Restricted Stock Units |
TJX Companies, Inc.
|
Ernie L. Herrman
|
Director, CEO & President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
45,978 |
597,105
(0%)
|
0%
|
|
0
|
Common Stock |
TJX Companies, Inc.
|
Douglas W. Mizzi
|
SEVP - Group President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
45,263 |
274,725
(0%)
|
0%
|
|
0
|
Common Stock |
Ulta Beauty Inc
|
Kecia Steelman L.
|
President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
44,429 |
44,429
|
-
|
|
-
|
Stock Option (right to buy) |
Unisys Corp.
|
Peter A. Altabef
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
44,248 |
1,371,708
(2%)
|
0%
|
|
0
|
Common Stock |
TJX Companies, Inc.
|
Kenneth Canestrari
|
SEVP - Group President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
43,754 |
140,212
(0%)
|
0%
|
|
0
|
Common Stock |
AMMO Inc
|
Jared R. Smith
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
43,333 |
479,807
|
-
|
|
0
|
Common Stock |
Solid Power Inc - Ordinary...
|
John C. Van Scoter
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. |
31 Mar 2025 |
42,841 |
1,267,609
|
-
|
1.1 |
46,268
|
Common Stock |
Nauticus Robotics Inc
|
Victoria Hay
|
Interim CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
42,798 |
42,798
|
-
|
|
-
|
Restricted Stock Units |
Hallador Energy Co
|
Heath Aaron Lovell
|
President-Hallador Power |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
40,864 |
81,728
|
-
|
|
-
|
RSU |
Abercrombie & Fitch Co. - ...
|
Samir Desai
|
EVP;Chief Digital&Tech Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
40,342 |
74,805
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Organon & Co.
|
Juan Camilo Arjona Ferreira
|
Head of R&D & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
40,295 |
40,295
|
-
|
|
-
|
Restricted Stock Units |
Organon & Co.
|
Kathryn DiMarco
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
40,295 |
40,295
|
-
|
|
-
|
Restricted Stock Units |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
40,000 |
0
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.82 per share. |
31 Mar 2025 |
40,000 |
159,009
(0%)
|
0%
|
15.8 |
632,800
|
Common Stock |
LifeMD Inc
|
Maria Stan
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
40,000 |
167,500
|
-
|
|
0
|
Common Stock |
LifeMD Inc
|
Maria Stan
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
40,000 |
127,500
|
-
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Marshall A. Heinberg
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
39,993 |
352,202
(0%)
|
0%
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Marshall A. Heinberg
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
39,993 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Procore Technologies Inc
|
Benjamin C. Singer
|
Chief Legal Officer; Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
39,531 |
111,641
|
-
|
|
0
|
Common Stock |
ON24 Inc
|
Sharat Sharan
|
Director, President and Chief Executive, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.23 per share. |
31 Mar 2025 |
39,196 |
3,164,092
|
-
|
5.2 |
205,187
|
Common Stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
38,974 |
260,687
|
-
|
|
0
|
Common Stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
38,974 |
38,974
|
-
|
|
-
|
Restricted Stock Units |
National Cinemedia Inc
|
Ronnie Y. Ng
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
38,750 |
0
|
-
|
|
-
|
Restricted Stock Units |
National Cinemedia Inc
|
Ronnie Y. Ng
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
38,750 |
161,289
(0%)
|
0%
|
|
0
|
Common Stock |
FrontView REIT Inc.
|
Timothy D. Dieffenbacher
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
37,286 |
37,286
|
-
|
|
-
|
Restricted Stock Units |
Hillenbrand Inc
|
Kimberly K. Ryan
|
President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
37,102 |
37,102
|
-
|
|
-
|
Restricted Stock Units (Matching RSU Framework 03/31/2025) |
Pyxis Oncology Inc
|
John L. Flavin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Freda C. Lewis-Hall
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Michael Metzger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Rachel Humphrey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Jakob Dupont
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Darren S. Cline
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pyxis Oncology Inc
|
Thomas Civik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,979 |
36,979
|
-
|
|
-
|
Stock Option (Right to Buy) |
Organon & Co.
|
Rachel A. Stahler
|
Chief Information Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,937 |
36,937
|
-
|
|
-
|
Restricted Stock Units |
Organon & Co.
|
Kirke Weaver
|
Gen. Counsel & Corp. Secy. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,937 |
36,937
|
-
|
|
-
|
Restricted Stock Units |
Hallador Energy Co
|
Heath Aaron Lovell
|
President-Hallador Power |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. |
31 Mar 2025 |
36,915 |
129,952
(0%)
|
0%
|
12.3 |
453,316
|
COMMON STOCK |
TJX Companies, Inc.
|
Carol Meyrowitz
|
Director, Executive Chairman |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. |
31 Mar 2025 |
36,474 |
208,610
(0%)
|
0%
|
121.8 |
4,442,533
|
Common Stock |
Ryerson Holding Corp.
|
Edward J. Lehner
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
36,300 |
36,300
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
35,868 |
121,668
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
35,868 |
35,868
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
35,868 |
106,643
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
35,868 |
35,868
|
-
|
|
-
|
Restricted Stock Units |
Lyell Immunopharma Inc
|
Otis W. Brawley
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.56 per share. |
31 Mar 2025 |
35,640 |
35,640
|
-
|
0.6 |
19,958
|
Common Stock |
Hallador Energy Co
|
Heath Aaron Lovell
|
President-Hallador Power |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. |
31 Mar 2025 |
35,482 |
131,385
(0%)
|
0%
|
12.3 |
435,719
|
COMMON STOCK |
National Cinemedia Inc
|
Thomas F. Lesinski
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.84 per share. |
31 Mar 2025 |
35,480 |
371,561
(0%)
|
0%
|
5.8 |
207,203
|
Common Stock |
Corcept Therapeutics Inc
|
Joseph K. Belanoff
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 94.72 per share. |
31 Mar 2025 |
35,102 |
2,982,335
(2%)
|
0%
|
94.7 |
3,324,861
|
Common Stock |
Beam Therapeutics Inc
|
Giuseppe Ciaramella
|
President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
35,000 |
197,650
(0%)
|
0%
|
|
0
|
Common Stock |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
35,000 |
56,571
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.56 per share. |
31 Mar 2025 |
35,000 |
44,009
(0%)
|
0%
|
13.6 |
474,600
|
Common Stock |
Liquidity Services Inc
|
Mateus-Tique Jaime
|
Director |
Sale of securities on an exchange or to another person at price $ 30.71 per share. |
31 Mar 2025 |
35,000 |
259,562
(0%)
|
0%
|
30.7 |
1,074,850
|
Common Stock |
Turtle Beach Corp
|
Cristopher Keirn
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
34,176 |
34,176
|
-
|
|
-
|
Restricted Stock Units |
Healthcare Triangle Inc
|
Shibu Kizhakevilayil
|
Director, Head of M&A |
|
31 Mar 2025 |
34,129 |
54,129
|
-
|
|
0
|
Common Stock |
Cipher Mining Inc
|
Patrick Kelly
|
Co-President and COO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
33,968 |
1,043,038
|
-
|
|
-
|
Common Stock |
Cipher Mining Inc
|
Patrick Kelly
|
Co-President and COO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
33,968 |
2,014,081
|
-
|
|
-
|
Restricted Stock Units |
Cipher Mining Inc
|
William Iwaschuk
|
Co-President and CLO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
33,968 |
2,014,081
|
-
|
|
-
|
Restricted Stock Units |
Cipher Mining Inc
|
William Iwaschuk
|
Co-President and CLO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
33,968 |
967,378
|
-
|
|
-
|
Common Stock |
Commercial Vehicle Group Inc
|
Angela M. O’Leary
|
VP, Controller & Ch Acct Offcr |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
33,955 |
83,927
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Palantir Technologies Inc ...
|
Ryan Taylor
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 83.44 per share. |
31 Mar 2025 |
33,159 |
426,119
|
-
|
83.4 |
2,766,823
|
Class A Common Stock |
Abbvie Inc
|
Jeffrey Ryan Stewart
|
EVP, CHIEF COMMERCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 210.54 per share. |
31 Mar 2025 |
33,132 |
53,234
(0%)
|
0%
|
210.5 |
6,975,611
|
Common Stock, $0.01 par value |
Corcept Therapeutics Inc
|
Joseph Douglas Lyon
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 101.37 per share. |
31 Mar 2025 |
32,942 |
14,059
(0%)
|
0%
|
101.4 |
3,339,416
|
Common Stock |
Timken Co.
|
Richard Kyle
|
Director, Interim President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
32,400 |
32,400
|
-
|
|
-
|
Performance Based-Restricted Stock Units |
GrafTech International Ltd.
|
Jean-Marc Germain
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
31,609 |
102,761
|
-
|
|
-
|
Deferred Share Units |
VYNE Therapeutics Inc
|
David Domzalski
|
Director, PRESIDENT AND CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. |
31 Mar 2025 |
30,498 |
445,563
(1%)
|
0%
|
1.6 |
48,187
|
Common Stock |
Hallador Energy Co
|
Marjorie A. Hargrave
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.28 per share. |
31 Mar 2025 |
30,267 |
30,267
(0%)
|
0%
|
12.3 |
371,679
|
Common Stock |
Maiden Holdings Ltd
|
William T. Jarman
|
SVP & Chief Actuary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
31 Mar 2025 |
30,092 |
208,249
(0%)
|
0%
|
|
0
|
Common Shares |
LifeMD Inc
|
Eric Yecies
|
Chief Legal Officer & GC |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
30,000 |
370,000
|
-
|
|
0
|
Common Stock |
LifeMD Inc
|
Stefan Galluppi
|
Chief Innovation Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
30,000 |
165,449
|
-
|
|
0
|
Common Stock |
GrafTech International Ltd.
|
Sachin M. Shivaram
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
29,741 |
29,741
|
-
|
|
-
|
Deferred Share Units |
Abercrombie & Fitch Co. - ...
|
Scott D. Lipesky
|
EVP and COO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. |
31 Mar 2025 |
29,210 |
134,524
(0%)
|
0%
|
76.4 |
2,230,768
|
Class A Common Stock |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. |
31 Mar 2025 |
29,093 |
108,933
|
-
|
1.8 |
53,531
|
Class A common stock |
Aura Biosciences Inc
|
Teresa Marie Bitetti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
29,000 |
29,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Macy`s Inc
|
Antony Spring
|
Director, Chairman & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
28,588 |
57,176
|
-
|
|
-
|
Restricted Stock Units |
Macy`s Inc
|
Antony Spring
|
Director, Chairman & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
28,588 |
349,832
(0%)
|
0%
|
|
0
|
Common Stock |
Shoe Carnival, Inc.
|
Mark J. Worden
|
Director, PRESIDENT & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.00 per share. |
31 Mar 2025 |
28,412 |
283,261
(1%)
|
0%
|
22 |
625,064
|
Common Stock |
Calumet Specialty Products...
|
Bruce Fleming
|
EVP - MONTANA RENEWABLES |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
28,320 |
28,320
|
-
|
|
-
|
Restricted Stock Unit |
Origin Materials Inc
|
John Hickox
|
Director |
Grant, award, or other acquisition of securities at price $ 0.66 per share. |
31 Mar 2025 |
28,254 |
588,288
|
-
|
0.7 |
18,749
|
Common Stock |
Full House Resorts, Inc.
|
Daniel R. Lee
|
Director, PRESIDENT & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
28,240 |
28,240
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Beam Therapeutics Inc
|
Amy Simon
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
27,500 |
96,305
(0%)
|
0%
|
|
0
|
Common Stock |
Citizens, Inc. - Ordinary ...
|
Gerald W. Shields
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,472 |
0
|
-
|
|
-
|
Restricted Stock Units |
Citizens, Inc. - Ordinary ...
|
Gerald W. Shields
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
27,472 |
27,472
|
-
|
|
-
|
Restricted Stock Units |
Citizens, Inc. - Ordinary ...
|
Gerald W. Shields
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,472 |
303,942
(0%)
|
0%
|
|
-
|
Citizens, Inc. Class A Common Stock |
Unisys Corp.
|
Peter A. Altabef
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. |
31 Mar 2025 |
27,406 |
1,327,460
(2%)
|
0%
|
4.6 |
125,794
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Betsy L. Battle
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
56,712
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Betsy L. Battle
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
James J. Martell
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
James J. Martell
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
41,151
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Ashok Vemuri
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
56,712
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Ashok Vemuri
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Kevin M. Fogarty
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
56,712
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Kevin M. Fogarty
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Scott Dols
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
56,712
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Scott Dols
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Mark S. Comora
|
Director, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
56,712
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Mark S. Comora
|
Director, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Nadeem Nisar
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
0
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
Nadeem Nisar
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
27,218 |
86,712
|
-
|
|
-
|
Class A common stock |
Jaguar Health Inc
|
James J. Bochnowski
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
31 Mar 2025 |
27,002 |
27,002
|
-
|
|
-
|
Convertible Promissory Note |
Jaguar Health Inc
|
James J. Bochnowski
|
Director |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
31 Mar 2025 |
27,002 |
27,002
|
-
|
|
-
|
Warrant to Purchase Common Stock |
Ardent Health Partners Inc
|
David Schultz
|
President Hospital Operations |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
26,985 |
64,172
|
-
|
|
0
|
Common Stock |
Stagwell Inc - Ordinary Sh...
|
Frank P. Lanuto
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
31 Mar 2025 |
26,974 |
661,276
|
-
|
|
0
|
Class A Common Stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. |
31 Mar 2025 |
26,964 |
221,713
|
-
|
14.5 |
391,248
|
Common Stock |
Custom Truck One Source Inc
|
Georgia R. Nelson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
26,859 |
26,859
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Mark D. Ein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
26,859 |
26,859
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Paul T. Bader
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
26,859 |
26,859
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Mary M. Jackson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
26,859 |
26,859
|
-
|
|
-
|
Restricted Stock Unit |
Omega Healthcare Investors...
|
Robert O. Stephenson
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
26,659 |
492,432
|
-
|
|
-
|
OP Units |
Omega Healthcare Investors...
|
Robert O. Stephenson
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
26,659 |
238,994
|
-
|
|
-
|
Profits Interest Units |
Lululemon Athletica inc.
|
Calvin R. McDonald
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
26,530 |
116,452
(0%)
|
0%
|
|
0
|
Common Stock |
Lululemon Athletica inc.
|
Calvin R. McDonald
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
26,530 |
0
|
-
|
|
-
|
Performance Share Units |
Stagwell Inc - Ordinary Sh...
|
Jay Leveton
|
President |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
31 Mar 2025 |
26,075 |
534,361
|
-
|
|
0
|
Class A Common Stock |
Occidental Petroleum Corp.
|
William R. Klesse
|
Director |
|
31 Mar 2025 |
25,900 |
208,889
(0%)
|
0%
|
21.3 |
551,670
|
Common Stock |
Occidental Petroleum Corp.
|
William R. Klesse
|
Director |
|
31 Mar 2025 |
25,900 |
3,860
|
-
|
|
-
|
Warrants (Right to buy) |
Lindblad Expeditions Holdi...
|
Natalya Leahy
|
CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,890 |
315,446
(0%)
|
0%
|
|
0
|
Common Stock |
GrafTech International Ltd.
|
Anthony R. Taccone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,862 |
168,911
|
-
|
|
-
|
Deferred Share Units |
Omega Healthcare Investors...
|
Robert O. Stephenson
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
25,738 |
265,653
|
-
|
|
-
|
Profits Interest Units |
Omega Healthcare Investors...
|
Robert O. Stephenson
|
CHIEF FINANCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
25,738 |
465,773
|
-
|
|
-
|
OP Units |
Abbvie Inc
|
Jeffrey Ryan Stewart
|
EVP, CHIEF COMMERCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
25,700 |
0
|
-
|
|
-
|
Option (Right to Buy) |
Abbvie Inc
|
Jeffrey Ryan Stewart
|
EVP, CHIEF COMMERCIAL OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. |
31 Mar 2025 |
25,700 |
112,066
(0%)
|
0%
|
79.0 |
2,030,814
|
Common Stock, $0.01 par value |
Abbvie Inc
|
Jeffrey Ryan Stewart
|
EVP, CHIEF COMMERCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 209.49 per share. |
31 Mar 2025 |
25,700 |
86,366
(0%)
|
0%
|
209.5 |
5,383,893
|
Common Stock, $0.01 par value |
Organon & Co.
|
Vittorio Nisita
|
Head of Global Business Svcs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,184 |
25,184
|
-
|
|
-
|
Restricted Stock Units |
Abeona Therapeutics Inc
|
Vishwas Seshadri
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 4.78 per share. |
31 Mar 2025 |
25,000 |
1,355,322
(1%)
|
0%
|
4.8 |
119,500
|
Common Stock |
Kymera Therapeutics Inc
|
Bruce Jacobs
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
25,000 |
69,899
|
-
|
|
-
|
Stock Option (Right to Buy) |
Kymera Therapeutics Inc
|
Bruce Jacobs
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. |
31 Mar 2025 |
25,000 |
226,886
|
-
|
2.1 |
52,000
|
Common Stock |
Cidara Therapeutics Inc
|
Shane M. Ward
|
COO & CLO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,000 |
39,674
(0%)
|
0%
|
|
0
|
Common Stock |
LifeMD Inc
|
Dennis Wijnker
|
Chief Technology Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,000 |
150,000
|
-
|
|
0
|
Common Stock |
Lindblad Expeditions Holdi...
|
Noah Brodsky
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,000 |
79,590
(0%)
|
0%
|
|
0
|
Common Stock |
AMMO Inc
|
Paul Joseph Kasowski
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
25,000 |
76,013
|
-
|
|
0
|
Common Stock |
First Guaranty Bancshares Inc
|
Bruce McAnally
|
Director |
Purchase of securities on an exchange or from another person at price $ 8.47 per share. |
31 Mar 2025 |
24,615 |
145,839
(1%)
|
0%
|
8.5 |
208,489
|
COMMON STOCK |
Origin Materials Inc
|
Craig A. Rogerson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.66 per share. |
31 Mar 2025 |
24,487 |
289,511
|
-
|
0.7 |
16,250
|
Common Stock |
OPAL Fuels Inc - Ordinary ...
|
Jonathan Maurer
|
Co-Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. |
31 Mar 2025 |
24,227 |
151,716
|
-
|
1.8 |
44,578
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
Adam Comora
|
Co-Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. |
31 Mar 2025 |
24,227 |
136,691
|
-
|
1.8 |
44,578
|
Class A common stock |
Snap Inc - Ordinary Shares...
|
Michael J. O'Sullivan
|
General Counsel |
Sale of securities on an exchange or to another person at price $ 8.60 per share. |
31 Mar 2025 |
24,000 |
507,660
(0%)
|
0%
|
8.6 |
206,386
|
Class A Common Stock |
Guardant Health Inc
|
Helmy Eltoukhy
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,998 |
2,421,453
(2%)
|
0%
|
|
0
|
Common Stock |
Guardant Health Inc
|
Helmy Eltoukhy
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,998 |
167,980
|
-
|
|
-
|
Restricted Stock Units |
Guardant Health Inc
|
AmirAli Talasaz
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,998 |
167,980
|
-
|
|
-
|
Restricted Stock Units |
Guardant Health Inc
|
AmirAli Talasaz
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,998 |
2,321,619
(2%)
|
0%
|
|
0
|
Common Stock |
Safehold Inc
|
Jay Sugarman
|
Director, CHAIRMAN AND CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. |
31 Mar 2025 |
23,926 |
1,804,622
(3%)
|
0%
|
|
0
|
Common Stock |
Palantir Technologies Inc ...
|
Ryan Taylor
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 82.40 per share. |
31 Mar 2025 |
23,913 |
459,278
|
-
|
82.4 |
1,970,496
|
Class A Common Stock |
Frontdoor Inc.
|
Jessica P. Ross
|
SVP & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
23,666 |
23,666
|
-
|
|
-
|
Restricted Stock Units |
Macy`s Inc
|
Adrian V. Mitchell
|
EVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,585 |
166,308
(0%)
|
0%
|
|
0
|
Common Stock |
Macy`s Inc
|
Adrian V. Mitchell
|
EVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,585 |
47,170
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,522 |
132,455
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
David Unger
|
Executive Vice President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,522 |
47,043
|
-
|
|
-
|
Restricted Stock Units |
OPAL Fuels Inc - Ordinary ...
|
John Coghlin
|
General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,521 |
80,959
|
-
|
|
-
|
Class A common stock |
OPAL Fuels Inc - Ordinary ...
|
John Coghlin
|
General Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,521 |
208,335
|
-
|
|
-
|
Restricted Stock Units |
Ryerson Holding Corp.
|
James J. Claussen
|
Executive Vice President & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,450 |
94,454
(0%)
|
0%
|
|
0
|
Common Stock (par value $0.01 per share) |
Dorian LPG Ltd
|
Oivind Lorentzen
|
Director |
Sale of securities on an exchange or to another person at price $ 23.11 per share. |
31 Mar 2025 |
23,386 |
48,933
(0%)
|
0%
|
23.1 |
540,450
|
Common Shares, $0.01 par value per share |
Hallador Energy Co
|
Marjorie A. Hargrave
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
23,351 |
46,702
|
-
|
|
-
|
Restricted Stock Unit |
Purple Innovation Inc - Or...
|
Robert T. DeMartini
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. |
31 Mar 2025 |
23,232 |
879,514
(4%)
|
0%
|
0.8 |
17,638
|
Class A Common Stock |
Palantir Technologies Inc ...
|
Ryan Taylor
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 84.26 per share. |
31 Mar 2025 |
22,948 |
403,171
|
-
|
84.3 |
1,933,507
|
Class A Common Stock |
Alto Ingredients Inc
|
Auste M. Graham
|
CLO & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. |
31 Mar 2025 |
22,677 |
255,281
(0%)
|
0%
|
1.1 |
25,398
|
Common Stock |
Wolfspeed Inc
|
Thomas H. Werner
|
Director, Executive Chair, Chairman of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
22,500 |
241,335
(0%)
|
0%
|
|
0
|
COMMON STOCK |
Ceco Environmental Corp.
|
Peter K. Johansson
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 22.80 per share. |
31 Mar 2025 |
22,500 |
62,160
(0%)
|
0%
|
22.8 |
512,933
|
Common Stock |
FrontView REIT Inc.
|
Drew Ireland
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
22,371 |
22,371
|
-
|
|
-
|
Restricted Stock Units |
Ardent Health Partners Inc
|
Stephen C. Petrovich
|
EVP, GC and Asst. Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
22,263 |
719,091
|
-
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Georgia R. Nelson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
105,804
(0%)
|
0%
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Georgia R. Nelson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Mark D. Ein
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
1,585,707
(3%)
|
0%
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Mark D. Ein
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Paul T. Bader
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
93,804
(0%)
|
0%
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Paul T. Bader
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Custom Truck One Source Inc
|
Mary M. Jackson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
55,173
(0%)
|
0%
|
|
0
|
Common Stock |
Custom Truck One Source Inc
|
Mary M. Jackson
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
22,218 |
0
|
-
|
|
-
|
Restricted Stock Unit |
Alto Ingredients Inc
|
Robert R. Olander
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share. |
31 Mar 2025 |
22,128 |
258,428
(0%)
|
0%
|
1.1 |
24,783
|
Common Stock |
Clearwater Analytics Holdi...
|
Sandeep Sahai
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,991 |
886,672
|
-
|
|
0
|
Class A Common Stock |
Clearwater Analytics Holdi...
|
Sandeep Sahai
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,991 |
329,861
|
-
|
|
-
|
Restricted Stock Unit |
TJX Companies, Inc.
|
Douglas W. Mizzi
|
SEVP - Group President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. |
31 Mar 2025 |
21,885 |
252,840
(0%)
|
0%
|
121.8 |
2,665,593
|
Common Stock |
Credo Technology Group Hol...
|
Chi Fung Cheng
|
Director, Chief Technology Officer |
Sale of securities on an exchange or to another person at price $ 40.04 per share. |
31 Mar 2025 |
21,574 |
7,993,602
|
-
|
40.0 |
863,896
|
Ordinary Shares |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. |
31 Mar 2025 |
21,553 |
239,134
|
-
|
14.5 |
312,734
|
Common Stock |
Amylyx Pharmaceuticals Inc
|
Joshua Cohen
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 3.47 per share. |
31 Mar 2025 |
21,490 |
3,355,280
|
-
|
3.5 |
74,482
|
Common Stock |
Amylyx Pharmaceuticals Inc
|
Justin Klee
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 3.46 per share. |
31 Mar 2025 |
21,490 |
3,355,276
|
-
|
3.5 |
74,454
|
Common Stock |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,472 |
0
|
-
|
|
-
|
Restricted Stock Units |
Organon & Co.
|
Kevin Ali
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,472 |
260,606
|
-
|
|
0
|
Common Stock |
Universal Technical Instit...
|
Adrienne DeTray
|
SVP and CIO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
21,242 |
21,242
(0%)
|
0%
|
|
0
|
Common Stock, $0.0001 par value |
Core & Main Inc - Ordinary...
|
Robyn Bradbury
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
21,192 |
21,192
|
-
|
|
-
|
Options (Rights to Buy) |
TJX Companies, Inc.
|
Kenneth Canestrari
|
SEVP - Group President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.80 per share. |
31 Mar 2025 |
21,156 |
119,056
(0%)
|
0%
|
121.8 |
2,576,801
|
Common Stock |
Purple Innovation Inc - Or...
|
Eric S. Haynor
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,101 |
42,202
|
-
|
|
-
|
Restricted Stock Units |
Purple Innovation Inc - Or...
|
Eric S. Haynor
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
21,101 |
213,034
(1%)
|
0%
|
|
-
|
Class A Common Stock |
Aura Biosciences Inc
|
Teresa Marie Bitetti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
21,000 |
21,000
|
-
|
|
0
|
Common Stock |
Ardent Health Partners Inc
|
Ethan Chernin
|
President of Health Services |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,914 |
35,988
|
-
|
|
0
|
Common Stock |
PPL Corp
|
David J. Bonenberger
|
EVP & COO-Utilities |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,770 |
20,770
|
-
|
|
-
|
Stock Unit (SIP) |
Lulus Fashion Lounge Holdi...
|
Dara Bazzano
|
Director, Board Chair |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,694 |
148,732
|
-
|
|
0
|
Common Stock |
Lindblad Expeditions Holdi...
|
Frederick Goldberg
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,496 |
70,496
(0%)
|
0%
|
|
0
|
Common Stock |
Stagwell Inc - Ordinary Sh...
|
Ryan Greene
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.93 per share. |
31 Mar 2025 |
20,395 |
190,597
|
-
|
5.9 |
120,942
|
Class A Common Stock |
Hillenbrand Inc
|
Robert M. VanHimbergen
|
Sr. VP, CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,239 |
20,239
|
-
|
|
-
|
Restricted Stock Units (Matching RSU Framework 03/31/2025) |
Organon & Co.
|
Daniel Karp
|
Executive VP, Corp. Dev. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,147 |
20,147
|
-
|
|
-
|
Restricted Stock Units |
Abercrombie & Fitch Co. - ...
|
Samir Desai
|
EVP;Chief Digital&Tech Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. |
31 Mar 2025 |
20,001 |
54,804
(0%)
|
0%
|
76.4 |
1,527,476
|
Class A Common Stock |
McCormick & Co., Inc. - Or...
|
Jeffery D. Schwartz
|
Vice President, Gen Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.96 per share. |
31 Mar 2025 |
20,000 |
89,958
(0%)
|
0%
|
50.0 |
999,200
|
Common Stock - Voting |
McCormick & Co., Inc. - Or...
|
Jeffery D. Schwartz
|
Vice President, Gen Counsel |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2025 |
20,000 |
20,000
|
-
|
|
-
|
Options - Right to Buy |
Lesaka Technologies Inc
|
Ali Haeri Mazanderani
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 4.96 per share. |
31 Mar 2025 |
20,000 |
525,115
(0%)
|
0%
|
5.0 |
99,200
|
Common Stock |
Beam Therapeutics Inc
|
Christine Bellon
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,000 |
122,968
(0%)
|
0%
|
|
0
|
Common Stock |
LifeMD Inc
|
Maria Stan
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,000 |
187,500
|
-
|
|
0
|
Common Stock |
LifeMD Inc
|
Maria Stan
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
20,000 |
207,500
|
-
|
|
0
|
Common Stock |